<?xml version="1.0" encoding="UTF-8"?>

<Group xmlns="http://hl7.org/fhir">
  <id value="H2Q-MC-LZZT-ResearchStudy-Inclusion"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><p><b>type</b>: person</p><p><b>actual</b>: false</p><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">Males and postmenopausal females at least 50 years of age.</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">Diagnosis of probable AD as defined by National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer’s Disease and Related Disorders Association (ADRDA) guidelines</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">MMSE score of 10 to 23.</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">Hachinski Ischemic Scale score of ≤4</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">CNS imaging (CT scan or MRI of brain) compatible with AD within past 1 year.</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">Investigator has obtained informed consent signed by the patient (and/or legal representative) and by the caregiver.</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">Geographic proximity to investigator’s site that allows adequate follow-up.</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title="Codes: ">A reliable caregiver who is in frequent or daily contact with the patient and who will accompany the patient to the office and/or be available by telephone at designated times, will monitor administration of prescribed medications, and will be responsible for the overall care of the patient at home. The caregiver and the patient must be able to communicate in English and willing to comply with 26 weeks of transdermal therapy.</span></p><p><b>value</b>: true</p><p><b>exclude</b>: false</p></blockquote></div>
  </text>
  <type value="person"/>
  <actual value="false"/>
  <characteristic>
    <code>
      <text value="Males and postmenopausal females at least 50 years of age."/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Diagnosis of probable AD as defined by National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer&#x2019;s Disease and Related Disorders Association (ADRDA) guidelines"/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="MMSE score of 10 to 23."/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Hachinski Ischemic Scale score of &#x2264;4"/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="CNS imaging (CT scan or MRI of brain) compatible with AD within past 1 year."/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Investigator has obtained informed consent signed by the patient (and/or legal representative) and by the caregiver."/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Geographic proximity to investigator&#x2019;s site that allows adequate follow-up."/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="A reliable caregiver who is in frequent or daily contact with the patient and who will accompany the patient to the office and/or be available by telephone at designated times, will monitor administration of prescribed medications, and will be responsible for the overall care of the patient at home. The caregiver and the patient must be able to communicate in English and willing to comply with 26 weeks of transdermal therapy."/>
    </code>
    <valueBoolean value="true"/>
    <exclude value="false"/>
  </characteristic>
</Group>